EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8

Claire L Williams iD, Ilaria Marzinotto iD, Cristina Brigatti, Kathleen M Gillespie iD, BOX Study Group, Vito Lampasona, Alistair J K Williams, Anna E Long iD

Clinical and Experimental Immunology · 19.02.2024 · 215 (3) · 215-224

DOI: 10.1093/cei/uxad139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 27.12.2023. Verfasst von Claire L Williams und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Health Sciences, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Cation Transport Proteins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes UK, KMG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Zinc transporter 8 autoantibodies (ZnT8A) are thought to appear close to type 1 diabetes (T1D) onset and can identify high-risk multiple (≥2) autoantibody positive individuals. Radiobinding assays (RBA) are widely used for ZnT8A measurement but have limited sustainability. We sought to develop a novel, high-performance, non-radioactive luciferase immunoprecipitation system (LIPS) assay to replace RBA.

Methods

A custom dual C-terminal ZnT8 (aa268-369; R325/W325) heterodimeric antigen, tagged with a NanoluciferaseTM (Nluc-ZnT8) reporter, and LIPS assay was developed. Assay performance was evaluated by testing sera from new onset T1D (n = 573), healthy schoolchildren (n = 521), and selected first-degree relatives (FDRs) from the Bart’s Oxford family study (n = 617; 164 progressed to diabetes).

Results

In new-onset T1D, ZnT8A levels by LIPS strongly correlated with RBA (Spearman’s r = 0.89; P < 0.0001), and positivity was highly concordant (94.3%). At a high specificity (95%), LIPS and RBA had comparable assay performance [LIPS pROC-AUC(95) 0.032 (95% CI: 0.029–0.036); RBA pROC-AUC(95) 0.031 (95% CI: 0.028–0.034); P = 0.376]. Overall, FDRs found positive by LIPS or RBA had a comparable 20-year diabetes risk (52.6% and 59.7%, respectively), but LIPS positivity further stratified T1D risk in FDRs positive for at least one other islet autoantibody detected by RBA (P = 0.0346).

Conclusion

This novel, high-performance, cheaper, quicker, higher throughput, low blood volume Nluc-ZnT8 LIPS assay is a safe, non-radioactive alternative to RBA with enhanced sensitivity and ability to discriminate T1D progressors. This method offers an advanced approach to current strategies to screen the general population for T1D risk for immunotherapy trials and to reduce rates of diabetic ketoacidosis at diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Cation Transport ProteinsHumansChildAutoantibodiesZinc Transporter 8LipLuciferasesImmunoprecipitation

Stichwörter der Autor:innen

LIPSautoantibodiesimmunoassaymethod developmentrisk predictiontype 1 diabetes

Substanzen

AutoantibodiesZinc Transporter 8Cation Transport ProteinsLuciferases

Autor:innen und Institutionen

  • Translational Health Sciences, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, UK.
  • San Raffaele Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

ORCID-Profile: Claire L Williams, Ilaria Marzinotto, Kathleen M Gillespie, Anna E Long

Förderung

  • Diabetes UK
  • KMG

Zitieren

APA

Williams, C. L., Marzinotto, I., Brigatti, C., Gillespie, K. M., BOX Study Group, Lampasona, V., Williams, A. J. K., & Long, A. E. (2024). A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8. Clinical and Experimental Immunology, 215(3), 215-224. https://doi.org/10.1093/cei/uxad139

Vancouver

Williams CL, Marzinotto I, Brigatti C, Gillespie KM, BOX Study Group, Lampasona V, et al. A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8. Clinical and Experimental Immunology. 2024;215(3):215-224. doi:10.1093/cei/uxad139

BibTeX
@article{Williams2024,
  author = {Williams, Claire L and Marzinotto, Ilaria and Brigatti, Cristina and Gillespie, Kathleen M and BOX Study Group, BOX Study Group and Lampasona, Vito and Williams, Alistair J K and Long, Anna E},
  title = {A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8},
  journal = {Clinical and Experimental Immunology},
  year = {2024},
  volume = {215},
  number = {3},
  pages = {215--224},
  doi = {10.1093/cei/uxad139}
}
Kostenlos starten →